AstraZeneca ups stake in Cellectis in latest cell therapy bet
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Mark Dunoyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan. The Cambridge,...